Neurocrine Bioscience buy melinda
Start price
10.03.17
/
50%
€40.53
Target price
12.04.17
€48.71
Performance (%)
11.98%
End price
12.04.17
€45.39
Summary
This prediction ended on 12.04.17 with a price of €45.39. The BUY prediction by melinda finished with a performance of 11.98%. melinda has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| Neurocrine Bioscience | -3.771% | -3.771% | 31.426% | 74.824% |
| iShares Core DAX® | -1,11 % | -0,85 % | 2,02 % | 51,34 % |
| iShares Nasdaq 100 | -4,35 % | -5,76 % | 26,25 % | 78,91 % |
| iShares Nikkei 225® | -6,79 % | -10,34 % | 53,21 % | 67,90 % |
| iShares S&P 500 | -1,79 % | -0,33 % | 21,46 % | 65,97 % |
Comments by melinda for this prediction
In the thread Neurocrine Bioscience diskutieren
Gilles de la Tourette-Syndrom - Juvenile
folgen
(Vom Mitglied beendet)
Stopped prediction by melinda for Neurocrine Bioscience
Neurocrine Bioscience
Start price
Target price
Perf. (%)
€98.42
25.01.21
25.01.21
€100.00
25.01.22
25.01.22
-30.50%
26.01.22
26.01.22
Neurocrine Bioscience
Start price
Target price
Perf. (%)
€18.02
11.12.14
11.12.14
€19.50
11.06.15
11.06.15
103.97%
11.06.15
11.06.15
Neurocrine Bioscience
Start price
Target price
Perf. (%)
€11.47
07.01.14
07.01.14
€9.50
07.07.14
07.07.14
0.60%
07.07.14
07.07.14
Neurocrine Bioscience
Start price
Target price
Perf. (%)
€9.57
19.06.13
19.06.13
€11.00
19.12.13
19.12.13
-30.71%
19.12.13
19.12.13


